hfsp research grants support innovative basic research into fundamental biological problems with emphasis placed on novel and interdisciplinary approaches that involve scientific exchanges across national and disciplinary boundaries (see guidelines).

participation of scientists from disciplines outside the traditional life sciences such as biophysics, chemistry, computational biology, computer science, engineering, mathematics, nanoscience or physics is recommended because such collaborations have opened up new approaches for understanding the complex structures and regulatory networks that characterize living organisms, their evolution and interactions.

research grants are provided for teams of scientists from different countries who wish to combine their expertise in innovative approaches to questions that could not be answered by individual laboratories. preliminary results are not required and applicants are expected to develop new lines of research through the research collaboration.

it is understood that such research inherently contains risks and hfsp expects that teams of applicants address the risks and outline mitigation strategies for their research in case of failure and how they intend to achieve their goals.

applications for applied research, including medical research typically funded by national medical research bodies, will be deemed ineligible (see guidelines).

two types of grant are available: research grants – early career and research grants – program.

for more information, please contact jill sherman at intl.research@lakeheadu.ca

this funding opportunity is seeking submissions from researchers to conduct a scoping review on the available peer reviewed research and grey literature on the experiences and biopsychosocial impacts of perimenopause, menopause and post-menopause on women veterans’ health and well-being outcomes.

researchers are encouraged to use a broad search strategy so that applicable research from different militaries and contexts is included. research conducted internationally, including the united states of america, united kingdom, new zealand and australia, should be considered. sub-analysis or interpretation may be needed for each country to show availability of research and literature between countries and what is most relevant to the canadian women veteran population.

studies from grey literature should be captured in addition to peer-reviewed literature and publications on information about women veterans’ and the civilian women populations’ experiences with perimenopause, menopause and post menopause are to be included. sub-analysis or interpretation may be needed to demonstrate generalizability to women veterans of the canadian armed forces.

partnership engage grants are expected to respond to the objectives of the research partnerships program.

these grants provide short-term and timely support for partnered research activities that will inform decision-making at a single partner organization from the public, private or not-for-profit sector. the small-scale, stakeholder-driven partnerships supported through partnership engage grants are meant to respond to immediate needs and time constraints facing organizations in non-academic sectors. in addressing an organization-specific need, challenge and/or opportunity, these partnerships let non-academic organizations and postsecondary researchers access each other’s unique knowledge, expertise and capabilities on topics of mutual interest.

this award recognizes a new investigator for outstanding contributions to research in the field of psychosocial oncology. candidates must be within seven years of completing their postgraduate, fellowship or equivalent specialist training (defined as a phd or md or equivalent). recipient will be announced at the annual capo conference in toronto from april 23-25, 2025. 

nominations due: january 31, 2025

learn more.

this award recognizes an individual who has made significant research contributions to the field of psychosocial oncology. recipient will be announced at the annual capo conference in toronto from april 23-25, 2025. 

nominations due: january 31, 2025

learn more.

the seniors community grants range from $1,000 to $25,000. these grants support community organizations and not-for-profit community groups to promote greater social inclusion, volunteerism, and community engagement for older adults aged 55+.

these grants fund projects that help seniors:

• live independently
• live with safety and security
• stay connected to their community
• avoid isolation
• achieve greater financial security and social connections

the gates foundation and lifearc^* have launched a joint grand challenges request for proposals, "innovations for exceptionally low-cost monoclonal antibody (mab) manufacturing".

monoclonal antibodies are one of the most powerful tools in modern medicine. they are highly specific, safe, and effective medicines for a range of conditions, including treating non-communicable diseases and preventing and treating infectious diseases. these biologic therapies already save lives and improve the quality of life for many millions of patients, but high production costs continue to limit access to mabs, especially for patients in low- and middle-income settings. while there are indication-specific dosage requirements for mabs, it is broadly understood that to close the equity gap in mab global access, we need to reach a target cost of $10 per gram of purified, released mab, a goal long championed by our late colleague, dr. steve hadley, former senior program officer at the gates foundation.

this grand challenge is calling for proposals that offer radical, innovative, and technically feasible pathways to achieving the $10/gram target. we invite you to bring your expertise, creativity, and passion to this effort and help shape a future where the best medical treatments are available to everyone, everywhere.

the gates foundation and lifearc are collaborating on this request for proposals to support a range of different approaches and build a critical mass of scientific innovation focused on reaching the target. while the organizations will employ a coordinated review process, individual grants will be funded either by the gates foundation or by lifearc.

applications for proof-of-concept projects (option a) are due by 11:30 am. pst on january 31st, 2025.

additionally, the gates foundation is interested in proposals from organizations that have already completed proof-of-concept work with feasible pathways to achieving the $10/gram and are interested in additional support (option b). applicants may apply with solutions meeting the criteria for either option a or option b, but not both.

applications for option b are due by 11:30 am. pst on may 31st, 2025.

please review the full details for both opportunities on our grand challenges website.

please contact jill sherman at intl.research@lakeheadu.ca for more information.

the gates foundation and lifearc^* have launched a joint grand challenges request for proposals, "innovations for exceptionally low-cost monoclonal antibody (mab) manufacturing".

monoclonal antibodies are one of the most powerful tools in modern medicine. they are highly specific, safe, and effective medicines for a range of conditions, including treating non-communicable diseases and preventing and treating infectious diseases. these biologic therapies already save lives and improve the quality of life for many millions of patients, but high production costs continue to limit access to mabs, especially for patients in low- and middle-income settings. while there are indication-specific dosage requirements for mabs, it is broadly understood that to close the equity gap in mab global access, we need to reach a target cost of $10 per gram of purified, released mab, a goal long championed by our late colleague, dr. steve hadley, former senior program officer at the gates foundation.

this grand challenge is calling for proposals that offer radical, innovative, and technically feasible pathways to achieving the $10/gram target. we invite you to bring your expertise, creativity, and passion to this effort and help shape a future where the best medical treatments are available to everyone, everywhere.

the gates foundation and lifearc are collaborating on this request for proposals to support a range of different approaches and build a critical mass of scientific innovation focused on reaching the target. while the organizations will employ a coordinated review process, individual grants will be funded either by the gates foundation or by lifearc.

applications for proof-of-concept projects (option a) are due by 11:30 am. pst on january 31st, 2025.

additionally, the gates foundation is interested in proposals from organizations that have already completed proof-of-concept work with feasible pathways to achieving the $10/gram and are interested in additional support (option b). applicants may apply with solutions meeting the criteria for either option a or option b, but not both.

applications for option b are due by 11:30 am. pst on may 31st, 2025.

please review the full details for both opportunities on our grand challenges website.

please contact jill sherman for more information at intl.research@lakeheadu.ca.